News about Market

Gilead Sciences to Acquire Ouro Medicines in USD 2 Billion Deal to Strengthen Immunology Pipeline

Gilead Sciences has announced a definitive agreement to acquire Ouro Medicines in a deal valued at over USD 2 billion, marking a strategic move to expand its immunology and inflammation pipeline.

Market | 24/03/2026 | By Darshana |  130

CVC and Apollo Partner to Accelerate Syntegon's Next Growth Phase

CVC has reaffirmed its confidence in Syntegon’s growth strategy as Apollo acquires a 37 percent minority stake to support expansion—particularly in the US—following strong performance that saw revenue reach a record €1.75 billion and operating profit quadruple, with further growth planned under CEO Torsten Türling.

Market | 23/03/2026 | By News Bureau |  207

Abbott Laboratories Set to Close Exact Sciences Acquisition, Strengthens Position in Cancer Diagnostics

The acquisition marks a significant strategic move for Abbott, enabling the company to expand into high-growth segments of cancer screening and diagnostics.

Market | 23/03/2026 | By Darshana |  376

Sun Pharma Launches Semaglutide Injection in India Under Noveltreat and Sematrinity

Sun Pharmaceutical Industries has introduced semaglutide injections in India under the brands Noveltreat and Sematrinity, expanding access to advanced therapies for chronic weight management and type 2 diabetes. The launch strengthens treatment options with multiple dose strengths tailored to patient needs alongside diet and lifestyle interventions.

Market | 21/03/2026 | By News Bureau |  828

Eris Lifesciences Launches Weekly Semaglutide Shot at INR 220 in India

Eris Lifesciences has launched a weekly Semaglutide injection starting at INR 220 per dose and plans to introduce a pen-device version in April, priced between INR 4,000 and INR 4,500 per month to enhance patient convenience and adoption.

Market | 21/03/2026 | By News Bureau |  614

Glenmark Pharma USA Launches Generic Milnacipran Tablets

Glenmark Pharmaceuticals USA has launched Milnacipran Hydrochloride tablets in multiple strengths as the authorised generic of Savella, expanding treatment access in the US market.

Market | 20/03/2026 | By News Bureau |  187

Natco to Launch Semaglutide Generic at 90 Percent Discount in India

Natco Pharma is set to launch a generic version of semaglutide in India at a sharply reduced price, signalling the start of an intense price competition in the diabetes and weight-loss drug segment.

Market | 20/03/2026 | By Darshana |  208

Novartis Signs Deal with Synnovation Therapeutics to Explore Next-Gen Breast Cancer Treatment

Novartis has signed a deal with Synnovation Therapeutics to advance SNV4818, a next-generation PI3Kα inhibitor in phase-I/II trials, targeting HR+/HER2- breast cancer patients with PIK3CA mutations, addressing a significant unmet need.

Market | 20/03/2026 | By News Bureau |  144

Glenmark Pharma USA Introduces Potassium Phosphates Injection USP

Glenmark Pharmaceuticals USA is set to launch Potassium Phosphates Injection USP in March 2026.

Market | 19/03/2026 | By News Bureau |  109

Strides Pharma Acquires Sandoz's Generic Brands to Expand African Business

Strides Pharma has acquired multiple generic brands from Sandoz to expand its African business, a move expected to position it among the top five pharma companies in Sub-Saharan Africa and more than double its regional presence.

Market | 19/03/2026 | By News Bureau |  179